The Eurovision Song Contest, celebrating its monumental 70th year, has officially partnered with ZOOP, an innovative social platform. This exciting collaboration establishes ZOOP as the dedicated ...

The Suunto Core 2 has been registered with the FCC It points to an imminent launch for the watch The wearable could come with a long-lasting, replaceable battery One problem with the best smartwatches ...

Eli Lilly & Co.’s new weight-loss pill Foundayo has gotten off to a sluggish start, according to new prescription data, an early sign of the challenge the drugmaker will have as it tries to catch up ...

Novo Nordisk once benefited from euphoric sentiment around the booming GLP-1 market. Rising competition and decelerating growth has inspired investors to rotate capital elsewhere. The company's ...

LONDON/COPENHAGEN, May 7 (Reuters) - Early data from weight-loss pills are lifting shares in Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab as investors bet that easier-to ...

Novo Nordisk’s CEO has insisted that plans to launch the GLP-1/amylin combo treatment CagriSema remain on track, despite the pharma ending hopes of delivering the therapy in a single-chamber device.

With the recent launch of Novo Nordisk’s Wegovy pill opening the oral GLP-1 market for obesity, the company has now unveiled positive results that could tee up an expansion in semaglutide’s inaugural ...

Scientists have created an anode-free sodium solid-state battery. This brings the reality of inexpensive, fast-charging, high-capacity batteries for electric vehicles and grid storage closer than ever ...

On April 14, Novo Nordisk announced that it had entered into a partnership with OpenAI. The two companies will collaborate to bring cutting-edge artificial intelligence (AI) capabilities to the drug ...